Gelens E - Search Results

1

Self-assembled nanofiber coatings for controlling cell responses.

Barros RC, Gelens E, Bulten E, Tuin A, de Jong MR, Kuijer R, van Kooten TG. Barros RC, et al. Among authors: gelens e. J Biomed Mater Res A. 2017 Aug;105(8):2252-2265. doi: 10.1002/jbm.a.36092. Epub 2017 May 17. J Biomed Mater Res A. 2017. PMID: 28513985

2

Nanofiber-based hydrogels with extracellular matrix-based synthetic peptides for the prevention of capsular opacification.

Nibourg LM, Gelens E, de Jong MR, Kuijer R, van Kooten TG, Koopmans SA. Nibourg LM, et al. Among authors: gelens e. Exp Eye Res. 2016 Feb;143:60-7. doi: 10.1016/j.exer.2015.10.001. Epub 2015 Oct 22. Exp Eye Res. 2016. PMID: 26474493

3

Prevention of posterior capsular opacification.

Nibourg LM, Gelens E, Kuijer R, Hooymans JM, van Kooten TG, Koopmans SA. Nibourg LM, et al. Among authors: gelens e. Exp Eye Res. 2015 Jul;136:100-15. doi: 10.1016/j.exer.2015.03.011. Epub 2015 Mar 14. Exp Eye Res. 2015. PMID: 25783492 Review.

4

Effects of peptide ratios in nanofibre-based hydrogels for the prevention of capsular opacification.

Nibourg LM, Gelens E, Nibourg SA, de Jong MR, Kuijer R, van Kooten TG, Koopmans SA. Nibourg LM, et al. Among authors: gelens e. Acta Ophthalmol. 2016 Nov;94(7):721-729. doi: 10.1111/aos.13047. Epub 2016 Apr 7. Acta Ophthalmol. 2016. PMID: 27062370 Free article.

5

Synthesis, Properties, and Two-Dimensional Adsorption Characteristics of 5-Amino[6]hexahelicene.

van der Meijden MW, Gelens E, Quirós NM, Fuhr JD, Gayone JE, Ascolani H, Wurst K, Lingenfelder M, Kellogg RM. van der Meijden MW, et al. Among authors: gelens e. Chemistry. 2016 Jan 22;22(4):1484-92. doi: 10.1002/chem.201502798. Epub 2015 Dec 14. Chemistry. 2016. PMID: 26662511

6

Syntheses and structure-activity relationships for some triazolyl p38α MAPK inhibitors.

Seerden JP, Leusink-Ionescu G, Leguijt R, Saccavini C, Gelens E, Dros B, Woudenberg-Vrenken T, Molema G, Kamps JA, Kellogg RM. Seerden JP, et al. Among authors: gelens e. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1352-7. doi: 10.1016/j.bmcl.2014.01.034. Epub 2014 Jan 28. Bioorg Med Chem Lett. 2014. PMID: 24508134

7

Structural aspects of nucleation inhibitors for diastereomeric resolutions and the relationship to dutch resolution.

Leeman M, Brasile G, Gelens E, Vries T, Kaptein B, Kellogg R. Leeman M, et al. Among authors: gelens e. Angew Chem Int Ed Engl. 2008;47(7):1287-90. doi: 10.1002/anie.200704021. Angew Chem Int Ed Engl. 2008. PMID: 18188854 No abstract available.

8

Solid-phase synthesis of 4-substituted imidazoles using a scaffold approach.

Gelens E, Koot WJ, Menge WM, Ottenheijm HC, Timmerman H. Gelens E, et al. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1935-8. doi: 10.1016/s0960-894x(00)00363-2. Bioorg Med Chem Lett. 2000. PMID: 10987421

9

4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.

Wijtmans M, Celanire S, Snip E, Gillard MR, Gelens E, Collart PP, Venhuis BJ, Christophe B, Hulscher S, van der Goot H, Lebon F, Timmerman H, Bakker RA, Lallemand BI, Leurs R, Talaga PE, de Esch IJ. Wijtmans M, et al. Among authors: gelens e. J Med Chem. 2008 May 22;51(10):2944-53. doi: 10.1021/jm7014149. Epub 2008 Apr 24. J Med Chem. 2008. PMID: 18433114

10

Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.

Kitbunnadaj R, Zuiderveld OP, Christophe B, Hulscher S, Menge WM, Gelens E, Snip E, Bakker RA, Celanire S, Gillard M, Talaga P, Timmerman H, Leurs R. Kitbunnadaj R, et al. Among authors: gelens e. J Med Chem. 2004 May 6;47(10):2414-7. doi: 10.1021/jm049932u. J Med Chem. 2004. PMID: 15115383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page